Search Results - Lars Pedersen
- Showing 1 - 20 results of 36
- Go to Next Page
-
1
Higher biosecurity level was associated with reduced risk of Danish dairy cattle farms becoming test-positive for Salmonella Dublin in a nested case–control study by Lars Pedersen, Lars Pedersen, Hans Houe, Erik Rattenborg, Liza Rosenbaum Nielsen
Published in Frontiers in Veterinary Science (2025-05-01)Get full text
Article -
2
-
3
-
4
-
5
Cardiovascular risk and mortality in men receiving testosterone replacement therapy for Klinefelter syndrome in Denmark: a retrospective cohort studyResearch in context by Simon Chang, Lars Pedersen, Anne Skakkebæk, Agnethe Berglund, Claus H. Gravholt
Published in The Lancet Regional Health. Europe (2025-04-01)Get full text
Article -
6
-
7
Development of a 5-year risk prediction model for type 2 diabetes in individuals with incident HbA1c-defined pre-diabetes in Denmark by Henrik T Sørensen, Lars Pedersen, Reimar W Thomsen, Sia K Nicolaisen, Cathrine J Lau
Published in BMJ Open Diabetes Research & Care (2022-09-01)Get full text
Article -
8
Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort study by Emil B.Riahi, Kasper Adelborg, Lars Pedersen, Søren R. Kristensen, Anette T. Hansen, Henrik T. Sørensen
Published in Research and Practice in Thrombosis and Haemostasis (2022-02-01)Get full text
Article -
9
Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort studyResearch in context by Henrik Toft Sørensen, Lars Pedersen, Nick van Es, Harry R. Büller, Erzsébet Horváth-Puhó
Published in The Lancet Regional Health. Europe (2023-11-01)Get full text
Article -
10
Migraine and risk of premature myocardial infarction and stroke among men and women: A Danish population-based cohort study. by Cecilia Hvitfeldt Fuglsang, Lars Pedersen, Morten Schmidt, Jan P Vandenbroucke, Hans Erik Bøtker, Henrik Toft Sørensen
Published in PLoS Medicine (2023-06-01)Get full text
Article -
11
Correction: Migraine and risk of premature myocardial infarction and stroke among men and women: A Danish population-based cohort study. by Cecilia Hvitfeldt Fuglsang, Lars Pedersen, Morten Schmidt, Jan P Vandenbroucke, Hans Erik Bøtker, Henrik Toft Sørensen
Published in PLoS Medicine (2024-02-01)Get full text
Article -
12
Prevalence of lifestyle characteristics in glucocorticoid users and non-users: a Danish population-based cross-sectional study by Irene Petersen, Henrik Toft Sørensen, Kristina Laugesen, Lars Pedersen, Finn Breinholt Larsen, Jens Otto Lunde Jørgensen
Published in BMJ Open (2019-10-01)Get full text
Article -
13
Major bleeding and thromboembolism risks of antithrombotic treatment in patients with incident atrial fibrillation/flutter and a history of cancer by Nienke van Rein, Gordon Chu, Menno V. Huisman, Lars Pedersen, Henrik T. Sørensen, Frederikus A. Klok, Suzanne C. Cannegieter
Published in Research and Practice in Thrombosis and Haemostasis (2025-02-01)Get full text
Article -
14
Major bleeding and thromboembolic complications associated with antithrombotic treatment in patients with atrial fibrillation/flutter and incident cancer by Gordon Chu, Nienke van Rein, Menno V Huisman, Lars Pedersen, Henrik T. Sørensen, Suzanne C. Cannegieter, Frederikus A. Klok
Published in Research and Practice in Thrombosis and Haemostasis (2025-02-01)Get full text
Article -
15
Preadmission Opioid Use and 1‐Year Mortality Following Incident Myocardial Infarction: A Danish Population‐Based Cohort Study (1997–2016) by Søren Korsgaard, Troels Munch, Erzsébet Horváth–Puhó, Kasper Adelborg, Christian Fynbo Christiansen, Lars Pedersen, Morten Schmidt, Henrik Toft Sørensen
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2023-03-01)Get full text
Article -
16
Risk of Parkinson Disease and Secondary Parkinsonism in Myocardial Infarction Survivors by Jens Sundbøll, Szimonetta Komjáthiné Szépligeti, Péter Szentkúti, Kasper Adelborg, Erzsébet Horváth‐Puhó, Lars Pedersen, Victor W. Henderson, Henrik Toft Sørensen
Published in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2022-03-01)Get full text
Article -
17
Neighborhood disadvantage and the risk of dementia and mortality among refugees to Denmark: A quasi-experimental study by Min Hee Kim, Else Foverskov, Trine Frøslev, Justin S. White, M. Maria Glymour, Jens Hainmueller, Lars Pedersen, Henrik T. Sørensen, Rita Hamad
Published in SSM: Population Health (2023-03-01)Get full text
Article -
18
Cohort profile: the Funen Diabetes Database—a population-based cohort of patients with diabetes in Denmark by Reimar Wernich Thomsen, Henrik Toft Sørensen, Jan Erik Henriksen, Lars Pedersen, Kasper Adelborg, Péter Szentkúti, Jens Sundbøll, Ole Hother-Nielsen, Henning Beck-Nielsen
Published in BMJ Open (2020-04-01)Get full text
Article -
19
Indirect comparison of efficacy of dupilumab versus mepolizumab and omalizumab for severe type 2 asthma by Katrine Prætorius, Daniel P. Henriksen, Johannes M. Schmid, Pernille Printzlau, Lars Pedersen, Hanne Madsen, Ehm A. Andersson, Louise Klokker Madsen, Bo L. Chawes
Published in ERJ Open Research (2021-08-01)Get full text
Article -
20
Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma – a systematic review and meta-analysis by Daniel P. Henriksen, Uffe Bodtger, Kirsten Sidenius, Niels Maltbaek, Lars Pedersen, Hanne Madsen, Ehm A. Andersson, Ole Norgaard, Louise Klokker Madsen, Bo L. Chawes
Published in European Clinical Respiratory Journal (2018-01-01)Get full text
Article
